Xilinx and TSMC Collaborate on 7nm Process for Next Generation of All Programmable FPGAs, MPSoCs, and 3D Ics

Xilinx, Inc. announced that it has collaborated with TSMC on the 7nm process and 3D IC technology for its next generation of All Programmable FPGAs, MPSoCs, and 3D ICs. The technology represents the fourth consecutive generation where the two companies have worked together on advanced process and CoWoS 3D stacking technology, and will become TSMC's fourth generation of FinFET technology. The collaboration will provide Xilinx a multi-node scaling advantage and build on its outstanding product, execution, and market success at 28nm, 20nm, and 16nm nodes.

"TSMC has been the foundation of our success at 28nm, 20nm, and 16nm, what we call our 3Peat," said Moshe Gavrielov, President and CEO of Xilinx. "Their outstanding process technology, 3D stacking technology, and foundry services have enabled Xilinx to build an unparalleled reputation for product excellence, quality, execution, and market leadership. They have also helped Xilinx transform its product portfolio with a new generation of SoCs, MPSoCs and 3D ICs, complementing its world class FPGAs. We believe TSMC's 7nm technology will be even more transformative for Xilinx."

"TSMC is pleased to work with Xilinx to enable its fourth generation of breakthrough products," said Mark Liu, President and Co-CEO of TSMC. "Our collaboration will bring about a new generation of scaling and 3D integration advantages, built on a proven track record of collaboration and execution by both companies."

Xilinx plans to introduce new 7nm products in 2017.

About Xilinx

Xilinx is the world's leading provider of All Programmable FPGAs, SoCs and 3D ICs. These industry-leading devices are coupled with a next-generation design environment and IP to serve a broad range of customer needs, from programmable logic to programmable systems integration. For more information, visit www.xilinx.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.